翰宇藥業(yè)：抗新冠鼻噴多肽項(xiàng)目HY3000將于近期提交IND申請(qǐng)

array(1) { [401330]=> array(2) { [2]=> array(3) { [0]=> string(12) "新冠疫情" [1]=> string(12) "翰宇藥業(yè)" [2]=> string(9) "多肽藥" } [4]=> array(1) { [0]=> string(19) "同花順7x24快訊" } } }